Electrical conduction block implant device

• US 8,409,268 B2
• Filed: 02/03/2010
• Issued: 04/02/2013
• Est. Priority Date: 03/03/2003
• Status: Expired due to Fees

• Current Assignee: Syntach AG
• Original Assignee: Syntach AG
• Inventors: Swanson, William, Cornelius, Richard, Schwartz, Robert S.
• Primary Examiner(s): SEVERSON, RYAN J
• Application Number:
  US12/699,749
• Publication Number:
  US 20100211155A1
• Time in Patent Office: 1,154 Days
• Field of Search: 623/1.11, 623/1.12, 623/1.15
• US Class Current: 623/1.11
• CPC Class Codes: A61B 17/320725 with radially expandable cutting or abrading elements A61B17/32075 takes precedence
• CPC Class Codes: A61F 2/2487 Devices within the heart chamber, e.g. splints
• CPC Class Codes: A61F 2/848 having means for fixation to the vessel wall, e.g. barbs
• CPC Class Codes: A61F 2/91 made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
• CPC Class Codes: A61F 2/915 with bands having a meander structure, adjacent bands being connected to each other
• CPC Class Codes: A61F 2002/8483 Barbs
• CPC Class Codes: A61F 2002/91525 within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
• CPC Class Codes: A61F 2002/91533 characterised by the phase between adjacent bands
• CPC Class Codes: A61F 2002/91558 connected peak to peak
• CPC Class Codes: A61F 2002/9511 the retaining means being filaments or wires
• CPC Class Codes: A61F 2002/9665 with additional retaining means
• CPC Class Codes: A61F 2220/0016 with sharp anchoring protrusions, e.g. barbs, pins, spikes
• CPC Class Codes: A61F 2230/0054 V-shaped

Abstract

The present invention provides an electrical block implant sized and shaped for securement at the perimeter of the pulmonary ostium of the left atrium. By utilizing various expandable ring designs and optional anchoring mechanisms, the present invention causes even, circular scarring around the perimeter of the pulmonary ostium, achieving reliable blocking of aberrant electrical signals responsible for atrial fibrillation.

Claims

1. A method of treating an atrial arrhythmia comprising:

delivering an unexpanded implant to a target site in an ostial region of a pulmonary vein;

expanding said implant to an initial retention state wherein said implant substantially conforms to a wall in said ostial region of said pulmonary vein; and

,

allowing said implant to continue to expand over time such that said implant migrates through an entire thickness of said wall of said pulmonary vein, said migration causing a circumferential scar tissue response of said pulmonary vein that treats said atrial arrhythmia.

2. A method according to claim 1, wherein the delivering of an unexpanded implant includes delivering a compressed stent.

3. A method according to claim 1, wherein the expanding of said implant includes expanding a spatial anchoring section of said implant.

4. A method according to claim 3, wherein the allowing of said implant to continue to expand includes allowing a conduction block inducing section of said implant to expand into said wall.

5. A method according to claim 1, wherein the expanding of said implant includes engaging retention surfaces in said wall of said pulmonary vein.

6. A method according to claim 5, wherein the engaging of said retention surfaces includes engaging barbs on said implant in said wall of said pulmonary vein.

7. A method according to claim 1, wherein the delivering of an unexpanded implant includes delivering an elongated implantable strip to said target site.

8. A method of creating an electrical conduction block in a pulmonary vein ostial region comprising:

directing an implant towards said ostial region in said pulmonary vein;

retaining said implant in said pulmonary vein with a first component of said implant;

expanding a second component of said implant independently relative to said first component of said implant; and

causing the formation of circumferential scar tissue in said ostial region of said pulmonary vein by allowing said second component of said implant to migrate into said ostial region.

9. A method according to claim 8, wherein the causing of said scar formation includes causing said second component to migrate through ostial region tissue.

10. A method according to claim 8, wherein the retaining of said implant includes expanding said first component to a size that causes an expansion force on the internal walls of said pulmonary vein.

11. A method according to claim 8, wherein the retaining of said implant includes abutting the implant against a bifurcation of said pulmonary vein.